ClinVar Miner

Submissions for variant NM_000191.3(HMGCL):c.286C>T (p.Gln96Ter)

dbSNP: rs890995574
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000673631 SCV000798857 likely pathogenic Deficiency of hydroxymethylglutaryl-CoA lyase 2018-03-27 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000673631 SCV003523183 pathogenic Deficiency of hydroxymethylglutaryl-CoA lyase 2022-06-02 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln96*) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with HMG-CoA lyase deficiency (PMID: 11461194). ClinVar contains an entry for this variant (Variation ID: 557482). For these reasons, this variant has been classified as Pathogenic.
Genome-Nilou Lab RCV000673631 SCV004172659 pathogenic Deficiency of hydroxymethylglutaryl-CoA lyase 2023-04-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.